BioCentury
ARTICLE | Clinical News

AclarusDx: Pilot trial started

November 7, 2011 8:00 AM UTC

This month, ExonHit will begin a U.S. pilot trial to evaluate AclarusDx in 160 patients with memory impairment. The product has CE Mark approval and is available in France. ...